Per Øyvind Enger

7.0k citations

66 papers · 3.6k indexed · h-index 32

Impact in

Genetics top 0.5%
- Glioma Diagnosis and Treatment
Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism

Papers in

Genetics 34
- Glioma Diagnosis and Treatment 33
Cancer Research 15
- Cancer, Hypoxia, and Metabolism 10

Co-authors: Rolf Bjerkvig Jian Wang Frits Thorsen Bente Sandvei Skeie Martha Chekenya Lina Leiss Linda Sleire Per Øystein Sakariassen
Journals: Cancer Research (7 papers)BMC Cancer (5 papers)World Neurosurgery (4 papers)Neuro-Oncology (4 papers)Neuropathology and Applied Neurobiology (4 papers)
Partner nations: Norway Luxembourg United States

In The Last Decade

Per Øyvind Enger

66 papers receiving 3.6k citations

Peers

Countries citing papers authored by Per Øyvind Enger

Since Specialization

Citations

This map shows the geographic impact of Per Øyvind Enger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Øyvind Enger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Øyvind Enger more than expected).

Fields of papers citing papers by Per Øyvind Enger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Øyvind Enger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Øyvind Enger. The network helps show where Per Øyvind Enger may publish in the future.

Co-authors

The 25 scholars most cited alongside Per Øyvind Enger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Øyvind Enger Line = papers co-authored together Per Øyvind Enger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Styryl Benzoic Acid Derivative DC10 Potentiates Radiotherapy by Targeting the xCT-Glutathione Axis Frontiers in Oncology ·Shahin Sarowar, Juan Bird, PE Bock, Rachael Motamed, 한근섭, 政一郎自見, Frode Selheim, Valentı́n Ceña, Hans‐René Bjørsvik, Per Øyvind Enger	2022	3
2	Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity iScience ·Areej Atamna, Xing‐Mei Zhang, Mengyuan Liao, Sara Bolin, Anne‐Laure Joly, Youssef Aoulad El Hadj Ali, Lina Leiss, Yiwen Jiang, Jonas Bergh, Eric C. Holland, Per Øyvind Enger, John Andersson, Fredrik J. Swartling, Hrvoje Miletić, Lene Uhrbom, Robert A. Harris, Charlotte Rolny	2018	38
3	Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts BMC Cancer ·Lina Leiss, 赵玉田 Zhao Yutian, Anne M. Øyan, Tao Yan, Oleg Tsinkalovsky, Linda Sleire, Kjell Petersen, Mohummad Aminur Rahman, Taianá De Oliveira, W Schaart, Mairtin Fishbein, Krishna M. Talasila, Hrvoje Miletić, Inge Jonassen, Xingang Li, Nicolaas H. C. Brons, Karl‐Henning Kalland, Jian Wang, Per Øyvind Enger	2017	9
4	Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy Oncotarget ·育雄鈴木, Lina Leiss, Ning Yang, Cecilie Brekke Rygh, Siddhartha S. Mitra, Samuel Cheshier, Irving L. Weissman, Bin Huang, Hrvoje Miletić, Rolf Bjerkvig, Per Øyvind Enger, Xingang Li, Jian Wang	2017	55
5	Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients Cancer Research ·Mev Dominguez–Valentin, Andrea Gras Navarro, Mohummad Aminur Rahman, Surendra Kumar, A. N. H. Weel, Elling Ulvestad, Vessela N. Kristensen, Morten Lund‐Johansen, Benedicte A. Lie, Per Øyvind Enger, Gro Njølstad, E. K. Kristoffersen, Stein Atle Lie, Martha Chekenya	2016	26
6	Rapid adherence to collagen IV enriches for tumour initiating cells in oral cancer European Journal of Cancer ·Kristina Xiao Liang, Tarig Osman, Dipak Sapkota, Evelyn Neppelberg, Pleasant W. Goode, Per Gunnar Liavaag, Anne Christine Johannessen, Mairtin Fishbein, Per Øyvind Enger, Daniela Elena Costea, Jian Wang	2014	9
7	Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma PLoS ONE ·Cecilie Brekke Rygh, Jian Wang, Marte Thuen, Andrea Gras Navarro, Else Marie Huuse, Frits Thorsen, Aurélie Poli, Jacques Zimmer, Olav Haraldseth, Stein Atle Lie, Per Øyvind Enger, Martha Chekenya	2014	24
8	Increased Survival Using Delayed Gamma Knife Radiosurgery for Recurrent High-Grade Glioma: A Feasibility Study World Neurosurgery ·Ernest Dodoo, Beate C. Huffmann, Inti Peredo, 杨星昊, Georges Sinclair, Theofilos G. Machinis, Per Øyvind Enger, Bente Sandvei Skeie, Paal‐Henning Pedersen, Marcus Ohlsson, Abiel Orrego, Suitbert Wrede, A. OSADOLOR, Hamza Benmakhlouf, Lars Herrman, Mikael Svensson, Bodo Lippitz	2014	18
9	Establishment of a Novel dsRed NOD/Scid Mouse Strain to Investigate the Host and Tumor Cell Compartments Cancer Investigation ·Mairtin Fishbein, Linda Sleire, Jian Wang, Inger Anne Netland, 赵玉田 Zhao Yutian, Hilde Elise Førde, Paal‐Henning Pedersen, Donald Gullberg, Per Øyvind Enger	2013	2
10	Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level Journal of Neuroimmunology ·Justyna Kmiecik, Aurélie Poli, Nicolaas H. C. Brons, Andreas Waha, Geir Egil Eide, Per Øyvind Enger, Jacques Zimmer, Martha Chekenya	2013	310
11	Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation BMC Cancer ·Ingrid Moen, K Bujnova, Jian Wang, Karl-Henning Kalland, Martha Chekenya, Lars A. Akslen, Linda Sleire, Per Øyvind Enger, Rolf K. Reed, Anne M. Øyan, Linda Stuhr	2012	17
12	Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide BMC Cancer ·Tao Yan, Kai Ove Skaftnesmo, Lina Leiss, Linda Sleire, Jian Wang, Xingang Li, Per Øyvind Enger	2011	50
13	Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma PLoS ONE ·Jian Wang, Agnete Svendsen, Justyna Kmiecik, Heike Immervoll, Kai Ove Skaftnesmo, Jesús Planagumà, Rolf K. Reed, Rolf Bjerkvig, Hrvoje Miletić, Per Øyvind Enger, Cecilie Brekke Rygh, Martha Chekenya	2011	87
14	Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged Survival World Neurosurgery ·Bente Sandvei Skeie, Geir Skeie, Per Øyvind Enger, Jeremy C. Ganz, Marcelo Reckelberg, Eloise Malle, L. Bracale, Nasrullah Mollah, Paal‐Henning Pedersen	2011	17
15	Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth Cancer Research ·Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire, Kai Ove Skaftnesmo, Rolf Bjerkvig, Tao Yan, Delphine Veautier, Andreas Persson, Per Øystein Sakariassen, Per Øyvind Enger	2010	69
16	The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling Oncogene ·Martha Chekenya, Camilla Krakstad, Agnete Svendsen, Inger Anne Netland, Vidar Staalesen, Berit B. Tysnes, Frode Selheim, Jian Wang, Per Øystein Sakariassen, Tone Sandal, Per Eystein Lønning, Torgeir Flatmark, Per Øyvind Enger, Rolf Bjerkvig, Mouldy Sioud, William B. Stallcup	2008	127
17	Lymphangiogenesis in colorectal cancer—Prognostic and therapeutic aspects International Journal of Cancer ·Eirik Sundlisæter, Grandhi S Chandragupta, Per Øystein Sakariassen, Karl Søndenaa, Per Øyvind Enger, Rolf Bjerkvig	2007	41
18	The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours Neuropathology and Applied Neurobiology ·Martha Chekenya, Per Øyvind Enger, Frits Thorsen, Berit B. Tysnes, Safa Al‐Sarraj, Tracy‐Ann Read, Tomasz Furmanek, Rupavathana Mahesparan, Joel M. Levine, Arthur M. Butt, G. J. Pilkington, Rolf Bjerkvig	2002	61
19	Local endostatin treatment of gliomas administered by microencapsulated producer cells Nature Biotechnology ·Tracy‐Ann Read, Dag R. Sørensen, Rupavathana Mahesparan, Per Øyvind Enger, Rupert Timpl, Bjørn R. Olsen, Mari H. B. Hjelstuen, Olav Haraldseth, Rolf Bjerkvig	2001	239
20	Cell encapsulation technology as a therapeutic strategy for CNSmalignancies Neuro-Oncology ·Therese Visted, Rolf Bjerkvig, Per Øyvind Enger	2001	62

About Per Øyvind Enger

Per Øyvind Enger is a scholar working on Genetics, Cancer Research, Oncology, Biotechnology and Immunology, having authored 66 papers that have together received 3.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (33 papers), Cancer Cells and Metastasis (13 papers), Cancer, Hypoxia, and Metabolism (10 papers), Brain Metastases and Treatment (8 papers), Immune cells in cancer (8 papers), Meningioma and schwannoma management (7 papers), Immune Cell Function and Interaction (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Genetics (1.1k citations), Cancer Research (701 citations), Oncology (1.2k citations), Developmental Neuroscience (152 citations) and Immunology (650 citations). Per Øyvind Enger has collaborated with scholars based in Norway, Luxembourg and United States. Frequent co-authors include Rolf Bjerkvig, Jian Wang, Frits Thorsen, Bente Sandvei Skeie, Martha Chekenya, Lina Leiss, Linda Sleire, Per Øystein Sakariassen, Agnete Svendsen and Inger Anne Netland. Their work appears in journals such as Cancer Research, BMC Cancer, World Neurosurgery, Neuro-Oncology and Neuropathology and Applied Neurobiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact